News

• 01.02.2019

  Congratulations to PD Dr. A. Curioni

  Congratulations to PD Dr. Alessandra Curioni for receiving a grant entitled «Generation of a comprehensive biobank for thoracic malignancies: patients’ data can predict responses to immunotherapy» from the Stiftung für angewandte Krebsforschung! mehr
• 03.01.2019

  Exploiting pathway dependence in HCL and HCL variant (extension of 2018 grant)

  Ex-vivo drug treatment with pathway inhibitors can be exploited to map signaling pathways that HCL cells depend on. Combination effects can then be used to build individual patient`s cellular “signaling maps”, which will foster personalized treatment approaches. By studying the effects of inhibitors on cellular structure, signaling an gene expression we envision to understand major disease drivers of both HCL and HCL variant. mehr
• 03.01.2019

  Congratulations to Paul Kachel

  Congratulations to Paul Kachel for receiving a competitive Helmut Horten Foundation grant on the project “Drug Response in Patients with Multiple Myeloma”! mehr